跳到正文
原文
Endpoints News 生物医药· Nicole DeFeudis·· 3 天前AI 评分40

AstraZeneca 和 Alexion 的 MG 治疗药物 Klygefa 获 FDA 批准

AstraZeneca, Alexion's myasthenia gravis treatment enters crowded market

AI 导读

AstraZeneca 和 Alexion 的 MG 治疗药物 Klygefa(通用名:gefurulimab)获 FDA 批准,作为首个用于治疗成人全身性肌无力症的自注射药物。

正文

As­traZeneca and Alex­ion won FDA ap­proval Mon­day for their self-ad­min­is­tered gen­er­al­ized myas­the­nia gravis (gMG) drug Klyge­fa.

The drug, al­so known as ge­fu­rulimab, is a once-week­ly …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news